Find Academic Supervisors

Maryam ShahiView profile

Researcher

• Endometrial Carcinoma
• Placental Pathology
• Gynecologic Oncology
• +4 more

Maryam Shahi, M.D., is a pathologist affiliated with the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota. She joined Mayo Clinic in 2020 after completing specialized training in Anatomic and Clinical Pathology, Cytopathology, Oncologic Pathology, and Gynecologic Pathology at institutions including the University of Minnesota, Memorial Sloan Kettering Cancer Center, and Johns Hopkins Hospital. Her research focuses on tumors of the female genital tract (particularly endometrial carcinoma), placental pathology, and molecular classification in gynecologic oncology. Medical Degree: Kermanshah University of Medical Sciences, Iran. Residency: University of Minnesota (Anatomic and Clinical Pathology). Fellowships: Cytopathology (University of Minnesota), Oncologic Pathology (Memorial Sloan Kettering), Gynecologic Pathology (Johns Hopkins), Molecular Genetic Pathology (Mayo Clinic). Her scientific work spans endometrial cancer prognosis, molecular characterization of gynecologic tumors, computer-aided diagnostic tools, and rare trophoblastic neoplasms. Recent publications highlight collaborations across 20+ institutions, emphasizing sentinel lymph node metastasis, myometrial invasion thresholds, and genetic syndromes in cancer risk. In 2017, she received the Ernst award for her abstract on thyroid nodule cytomorphology. She maintains active memberships in the International Society of Gynecological Pathology, American Society for Clinical Pathology, and College of American Pathologists. Her work bridges clinical practice, diagnostic innovation, and translational research in gynecologic oncology.

• Gynecologic oncology
• Ovarian cancer
• Cervical cancer
• +9 more

Innocenza Palaia, MD, PhD, is Associate Professor of Obstetrics & Gynecology at Sapienza University of Rome, Department of Maternal and Child Health and Urological Sciences, and Senior Consultant and Head of the Gynecologic Oncology Unit at Policlinico Umberto I, Rome. Education & Training 1998 – MD, Catholic University of the Sacred Heart, Rome 2004 – Residency in Obstetrics & Gynecology, University of Rome Tor Vergata 2009 – PhD in Perinatal Medicine and Gynecologic Oncology, Sapienza University 2001 – 12-month Fellowship, Jackson Memorial Hospital, Miami (US) Research Interests Her translational and clinical research focuses on the entire spectrum of gynecologic oncology, with particular emphasis on ovarian, cervical and endometrial cancers. She investigates precision medicine approaches including BRCA mutational profiling, PARP-inhibitor therapy, HPV-related carcinogenesis and vaccination, sentinel-node mapping, and peri-operative strategies to improve surgical outcomes and quality of life in cancer survivors. Scientific Awards & Honors 1999 – Award for Best Medical Thesis, Giuseppe Toniolo Institute 2004 – AIUG Award “Best Under-35 Researcher” 2007 – AAGL Award “Best Selected Paper by Young Surgeon” Grants & Supervision Since 2003 she has been Principal or Co-Investigator on >25 competitive research grants (total value >€400 000) from Sapienza University, PRIN and AIRC. She currently leads three active institutional projects on COVID-19 collateral damage in women’s health, end-of-life care in ovarian cancer, and peri-operative nutrition. She has supervised numerous PhD students and has been thesis advisor for 13 medical and midwifery graduates (2020-2024). Clinical & Academic Leadership She directs the Gynecologic Oncology Unit at Policlinico Umberto I, managing 16 in-patients daily and performing >1 000 oncologic visits yearly. She is President of the Midwifery Degree Course in Viterbo (second mandate) and teaches integrated pathology, gynecology & obstetrics in medicine, midwifery and nursing curricula across Sapienza campuses.

• Medical Imaging
• Surgical Oncology
• Optical Imaging
• +3 more

Stijn Keereweer and Denise Hilling are Principal Investigators at the Erasmus MC , leading the Dutch Fluorescence-Guided Surgery Group . Their collaborative work spans eight surgical disciplines, integrating advanced optical imaging technologies with clinical practice. Departments Involved: Otorhinolaryngology, Surgical Oncology, Radiology & Nuclear Medicine, Plastic Surgery, Cardiothoracic Surgery Key Collaborations: Leiden University Medical Center, TU-Delft Imaging Physics Research focuses on fluorescence-guided surgery for tumor delineation and vital structure identification, with clinical trials like "Guided by Light" for oral cancer and "STELLAR" for laryngeal cancer. Their work combines Raman spectroscopy with fluorescence imaging, creating novel diagnostic frameworks. Selected publications (2021-2024) emphasize bowel perfusion assessment , lymph node imaging , and multimodal surgical guidance . Current projects include the TRIPHASE trial for ureter visualization and IMPACT for trauma surgery perfusion imaging. Scientific Awards & Funding Erasmus MC-TKI-LSH Match Call II (€606,770) Michel Keijzer Fonds Grant (€100,000) Team Westland Funding (€161,000) Dutch Cancer Society Young Investigator Grant (€497,935) They mentor multiple PhD candidates and postdocs while maintaining partnerships with Single Quantum B.V. and the Technology Transfer Office . Their pathology pipeline standardization enables precise evaluation of imaging technologies.

Richard G. MooreView profile

Professor

• Gynecologic Oncology
• Robotic Surgery
• Cancer Biomarkers
• +7 more

Richard G. Moore, M.D., is a Professor in the Department of Obstetrics and Gynecology at the University of Rochester Medical Faculty Group . His clinical practice focuses on Gynecologic Oncology , with expertise in ovarian, endometrial, and cervical malignancies , sentinel lymph node mapping , and ovarian cancer biomarker research . Dr. Moore emphasizes a multidisciplinary team approach and individualized patient care. Education: M.D. from University of Alberta School of Medicine (1993), Residency in Obstetrics & Gynecology at Eastern Virginia Medical School (1993-1997), Fellowship in Gynecologic Oncology at Brown University School of Medicine (1999-2002) Dr. Moore's research interests span biomarker development for ovarian cancer , immunotherapy , targeted drug delivery , and novel surgical techniques . His work includes clinical trials on PARP inhibitors , immune checkpoint modulators , and plant-based dietary interventions . Recent studies focus on HE4's role in tumor immunosuppression and Forchlorfenuron analogs . His scientific contributions include patents for novel anticancer compounds and biomarker-based screening algorithms . Awards highlight his teaching excellence and research innovation , including multiple recognitions from the Consumer's Research Council of America and New England Association of Gynecologic Oncologists .

Sanjiv S. VirdeeView profile

Associate Professor

• Nuclear Medicine
• Diagnostic Radiology
• Vascular Imaging
• +4 more

Sanjiv S. Virdee is an Associate Professor in the Department of Imaging Sciences at the University of Rochester Medical Center, School of Medicine and Dentistry. His clinical focus includes vascular and interventional radiology, with expertise in nuclear medicine and advanced imaging techniques like SPECT/CT and PET/CT. His research interests integrate Medical Imaging with Machine Learning for diagnostic applications in Breast Cancer and lymphatic systems. Key areas include SPECT/CT Sentinel Node Imaging , Metastatic Infiltration Prediction , and Hybrid Imaging Modalities . Publications highlight innovations in vascular intervention (e.g., Onyx embolization for aneurysms) and urological management (e.g., nephrostomy catheter complications). Collaborative work spans Diagnostic Radiology , Oncologic Imaging , and Functional Imaging .

Katelyn C. HluskoView profile

Assistant Clinical Professor

• Veterinary Surgery
• Comparative Medicine
• Oncology
• +3 more

Katelyn C. Hlusko is a Clinical Assistant Professor in Small Animal Surgery at the Auburn University College of Veterinary Medicine , affiliated with the Department of Clinical Sciences. She is a Diplomate of the American College of Veterinary Surgeons (Small Animal) since 2022. Education: MS in Biomedical Sciences, Auburn University (2020) DVM, Mississippi State University (2015) BS in Animal and Nutritional Sciences, West Virginia University (2011) Research focuses on sentinel lymph node mapping , gastrostomy tube techniques , and tracheostomy outcomes in canine patients. Her work bridges diagnostic imaging, surgical oncology, and critical care applications. Scientific Awards: American College of Veterinary Surgeons Small Animal Surgery Student Award (2015) West Virginia University Foundation Outstanding Senior (2011) She has contributed to multiple publications in Veterinary Surgery , Veterinary Radiology & Ultrasound , and Journal of Veterinary Emergency and Critical Care , covering topics like lymphatic imaging, surgical device evaluation, and postoperative monitoring.

Ane Gerda Zahl ErikssonView profile

Associate Professor

• Gynaecological Oncology
• Endometrial Cancer
• Molecular Markers in Cancer
• +7 more

Ane Gerda Zahl Eriksson is an Associate Professor and senior consultant in the Department of Gynaecological Oncology at the Norwegian Radium Hospital, University of Oslo. She specializes in advanced minimally invasive surgery for gynaecologic cancers and radical procedures for advanced ovarian cancer, with a focus on surgical education. Dr. Eriksson holds a Medical Degree from the Medical University of Warsaw and completed her residency at Oslo University Hospital, followed by a fellowship in Gynaecologic Oncology at Memorial Sloan Kettering Cancer Center in 2015. Her research interests include sentinel lymph node biopsy implementation, molecular markers in endometrial cancer, and fertility preservation strategies. She is the founder and chair of the Advanced Course in Cytoreductive Surgery for Ovarian Cancer and a member of the ESGO Council. Dr. Eriksson has led clinical trials through the Nordic Society of Gynaecologic Oncology (NSGO), including the SENTICOL III trial, and has secured funding from the Sister Institution Fund in collaboration with MD Anderson. She mentors students and editorial fellows, and currently serves in the ESGO Gender Equity Program. Key professional roles include leadership in the NSGO Clinical Trials Unit, editorial work with the International Journal of Gynaecologic Cancer, and active membership in national/international societies. Her recent work focuses on cost-effectiveness analyses of lymph node biopsy techniques and outcomes of fertility preservation in cervical cancer patients.

• Medical Microbiology
• Infection Prevention
• Hepatitis Research
• +3 more

Dr. Edwina Doting is a Clinical Professor at the Faculty of Medical Sciences, University of Groningen. Her expertise spans Medical Microbiology, Infection Prevention, and Hepatitis Research. She has contributed to studies on microbial transmission in organ transplantation, probiotics’ effects in Alzheimer’s disease models, and spatiotemporal infection dynamics in healthcare settings. Her work aligns with UN SDGs addressing good health and well-being. Research outputs include peer-reviewed articles and a thesis on sentinel lymph node biopsy in cancer patients. She actively participates in academic leadership programs and media engagements on antibiotic use and infection control. Education: Completed a thesis on sentinel lymph node biopsy in breast cancer and melanoma (2007). Research Interests: Focuses on translational microbiology, infection prevention strategies, and diagnostic innovations in oncology and hepatology. Her work bridges clinical practice and public health. Publications: Recent studies highlight contributions to transplant medicine safety, neurodegenerative disease microbiome interactions, and hospital infection modeling. Earlier work established protocols in lymphoscintigraphy for breast cancer staging.

Antonio Piñero MadronaView profile

Associate Professor

• Hematology
• Hematopoietic Transplantation
• Cell Therapy
• +7 more

Antonio Piñero Madrona is an Associate Professor in the Department of Surgery, Pediatrics, Obstetrics and Gynecology at the University of Murcia's Faculty of Medicine. His research focuses on hematology, hematopoietic transplantation, cell therapy, and breast cancer treatment. He leads the 'Hematology, Hematopoietic Transplantation and Cell Therapy' research group and has contributed to consensus documents on sentinel lymph node biopsy and intraoperative radiotherapy in breast cancer. Education: Earned his Doctorate from the University of Murcia in 1998 with a thesis on parathyroid gland imaging in primary hyperparathyroidism. His clinical training includes roles in surgical oncology and interventional radiology. Research Interests: Prioritizes translational studies in breast cancer management, transcatheter valve interventions, and novel imaging techniques. Key areas include optimizing sentinel lymph node detection, managing post-neoadjuvant therapy outcomes, and advancing minimally invasive surgical technologies. Publications: Over 40 peer-reviewed articles since 2003, focusing on TAVI outcomes, inflammatory bowel disease treatment, and breast cancer consensus guidelines. His work frequently integrates clinical and methodological innovations in surgical oncology. Awards: No specific awards listed, but his contributions to multidisciplinary clinical guidelines reflect peer recognition. Grants & Advising: No explicit grant details provided. Thesis supervised by Dr. José Manuel Rodríguez González. Active in collaborative research networks including the Spanish TAVI registry and SESP-M breast cancer working group. Labs/Teams: Collaborates with the Hematology and Clinical Radiology research groups, focusing on translational surgical oncology and novel diagnostic platforms.

• Gynecologic Oncology
• Cancer Genetics
• Women’s Health
• +3 more

Dr. Marcia Ciccone is an Clinical Assistant Professor of Obstetrics and Gynecology and Fellowship Program Director for Gynecologic Oncology at the University of Southern California. Her work focuses on women’s health, particularly the genetic basis of gynecologic cancers and multidisciplinary cancer care. She completed her residency and fellowship at USC, emphasizing her commitment to comprehensive, patient-centered oncology care. Her research interests include cancer genetics, targeted therapies, and improving outcomes for patients with endometrial, cervical, and ovarian cancers. Notable contributions include studies on sentinel lymph node biopsy applications, chemoradiation outcomes, and managing adverse effects of immunotherapies like pembrolizumab. Dr. Ciccone’s publications (15+ recent articles) reflect a focus on surgical innovations, clinical trial advancements, and understanding genetic drivers of gynecologic malignancies. She advocates for patient education and long-term relationship-building in oncology care. While no formal awards are listed, her academic role and publication record highlight her expertise in gynecologic oncology. She advises no listed students but contributes to training future clinicians through her fellowship program. Her clinical practice integrates cutting-edge treatments with compassionate care, leveraging USC’s multidisciplinary resources to address complex cases such as placenta accreta spectrum and rare cancer metastases.

• Cancer Immunotherapy
• Tumor Microenvironment
• Immune Checkpoint Inhibitors
• +6 more

Fumito Ito, MD, PhD is an Associate Professor of Surgery and Molecular Microbiology and Immunology, with a focus on translational cancer immunology. He serves as Co-Leader of the Translational and Clinical Sciences Research (TACS) Program, driving investigations into immune cell dynamics and tumor interactions. Research Interests His work centers on: Immune checkpoint inhibitors and combination therapies in melanoma CX3CR1+ CD8 T-cell biology across cancers Dendritic cell engineering and neoantigen vaccination Tumor microenvironment modulation in resistant cancers Role of inflammasomes in immunotherapy-induced toxicity Publications Overview Recent publications highlight his expertise in melanoma immunology, gut microbiome dynamics, and dendritic cell-based therapies. Key trends include: Multi-omic profiling of brain metastases Notch signaling in stem cell-derived dendritic cell generation Mechanisms of T-cell exhaustion and persistence Preclinical validation of localized immunomodulatory strategies Labs and Teams He contributes to the TACS Program, bridging clinical and translational research to advance cancer immunotherapy protocols and biomarker discovery.

• Alternative Splicing
• Head & Neck Cancer
• Computational Biology
• +3 more

Theresa Guo is an Assistant Professor in the Department of Otolaryngology-Head & Neck Surgery at the University of California, San Diego (UCSD). With a background in mechanical engineering and medicine, her research focuses on post-transcriptional genomic alterations in head and neck cancers, particularly alternative splicing events that bridge DNA mutations and protein phenotypes. She employs computational biology approaches to advance precision cancer care. Education: BS in Mechanical Engineering, MIT MD, Cleveland Clinic Lerner College of Medicine Residency in Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital Fellowship in Head & Neck Surgical Oncology, MD Anderson Cancer Center Research Interests include alternative splicing in cancer, HPV-related oropharyngeal tumors, neoantigen discovery, and computational modeling of tumor heterogeneity. Her work addresses understudied gaps in genomic knowledge to improve therapeutic outcomes. Recent Publications highlight computational tools like OutSplice for splicing analysis, HPV oncogenic pathways, methylation-driven gene regulation, and clinical studies on treatment resistance and survival disparities. Key fields include head & neck oncology, molecular biology, and bioinformatics. Collaborations span multidisciplinary teams at UCSD and institutions like Johns Hopkins and MD Anderson, with co-authorships on studies involving immunotherapy, surgical outcomes, and epigenetic mechanisms.

• Surgical Oncology
• Breast Surgery
• Reconstructive Surgery
• +3 more

Associate Professor Sanjay Warrier is affiliated with the Department of Surgery at the Central Clinical School, University of Sydney. His academic role focuses on surgical oncology and breast surgery. Research interests include reconstructive techniques, imaging applications in surgery, and outcomes analysis in breast cancer treatments. Key publications in 2024 explore predictive angiographic methods for mastectomy complications, imaging agents for lymph node biopsies, and comparative analyses of breast cancer surgical approaches. No scientific awards or grants are explicitly listed in the provided materials. He currently has no listed doctoral/master's advisees. His work contributes to advancements in surgical precision and patient outcomes within oncological contexts.

Christopher S. HollenbeakView profile

Professor

• Health Economics
• Cost-Effectiveness Analysis
• Medical Decision Making
• +4 more

Christopher S. Hollenbeak is Professor and Chair of Health Policy and Administration, as well as Professor in the Department of Surgery and Public Health Sciences at The Pennsylvania State University. He holds a PhD in Economics from Washington University in St. Louis and has an extensive research portfolio focused on health economics, cost-effectiveness analysis, and clinical outcomes research. Education B.A., Economics, Brigham University M.A., Economics, Washington University in St. Louis Ph.D., Economics, Washington University in St. Louis His research interests span cost-effectiveness of medical interventions, health policy analysis, surgical outcomes, and heart failure management. Key projects include evaluating the financial impact of cancer treatments, analyzing end-of-life care in complex organizations, and studying resource utilization in chronic disease management. Recent publications focus on predictive modeling in endocrinology, cardiovascular surgery trends, and sleep-related outcomes in heart failure patients. His work frequently addresses health disparities, quality of care metrics, and economic implications of clinical decisions.

Fredrik StrandView profile

Researcher

• Artificial Intelligence
• Medical Imaging
• Breast Cancer Research
• +3 more

Fredrik Strand is a researcher at the Karolinska Institute , specifically within the Department of Oncology-Pathology under the Faculty of Medicine . He leads the Computational Breast Imaging Group , focusing on leveraging Artificial Intelligence (AI) for early breast cancer detection , precision diagnostics , and image-guided minimally invasive procedures . His work spans cross-disciplinary collaboration with institutions like the Royal Institute of Technology (KTH) and involves major clinical trials such as ScreenTrustCAD and ScreenTrustMRI . His research emphasizes AI in precision screening to address interval cancers and optimize radiologist workflows. Projects like VAI-B and RadioVal aim to validate AI algorithms and predict therapy response for neoadjuvant treatment . Recent publications highlight advancements in multi-modality imaging (mammography, MRI), GAN-based synthetic data generation , and trustworthy AI frameworks for clinical deployment. A consistent focus is on cost-effectiveness , equity in AI diagnostics , and human-AI interaction dynamics . Key trends in his work include deep learning for tumor detection , reinforcement learning for screening policies , and multi-institutional validation of AI tools. His research is funded by organizations such as Medtechlabs , Vinnova , EU Horizon Europe , and the Swedish Breast Cancer Association .